Medicine and Dentistry
Prevalence
100%
Epileptic Seizure
91%
Epidemiology
50%
Basal Ganglion Hemorrhage
50%
Psychogenic Non-Epileptic Seizure
50%
Polycythemia vera
50%
Erythrocytosis
50%
Gabapentinoid
50%
Brain Imaging
50%
Clinical Imaging
50%
Apoplexy
38%
Vertebral Artery
25%
Gabapentin
25%
Tertiary Care
25%
Controlled Substance
25%
Predictive Factor
25%
Factor A
25%
Treatment Option
25%
Pregabalin
18%
Putamen
16%
Neuropathic Pain
12%
Medical Record
12%
Surgical History
10%
Hypercoagulability
10%
Muscle Injury
10%
Anticoagulant
10%
Neurologic Finding
10%
Alcohol Intoxication
8%
Faintness
8%
Partial Thromboplastin Time
7%
Ictal
7%
Reperfusion Therapy
5%
Neuroscience
Cerebrovascular Accident
100%
Risk Factor
76%
Ictal
69%
Cognitive Disorder
50%
Psychogenic Non-Epileptic Seizure
50%
Pregabalin
50%
Bibliology
50%
Brain Imaging
50%
Focal Epilepsy
50%
Childhood Absence Epilepsy
50%
Diagnosis of Generalized Seizures
50%
Seizure Types
39%
Gabapentin
33%
Antiseizure Medication
28%
Anti-Seizure Medication
28%
Quality of Life
24%
Neuropathic Pain
16%
Mood Disorder
16%
Psychogeriatrics
16%
Thromboplastin
14%
Ischemic Heart Disease
14%
Status Epilepticus
9%
Diabetic Neuropathy
8%
Brain Ischemia
6%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
Cross-Sectional Study
54%
Migraine
50%
Factor A
50%
Gabapentinoid
50%
Clostridium Botulinum Type A
50%
Monoclonal Antibody
50%
Cerebrovascular Accident
40%
Pregabalin
37%
Headache
26%
Gabapentin
25%
Brain Ischemia
25%
Infection
25%
Diseases
25%
Coronavirinae
20%
SARS Coronavirus
15%
Joint Stiffness
14%
Thromboplastin
14%
Controlled Substance
12%
Neuropathic Pain
12%
Hypercoagulability
10%
Faintness
8%
Ischemic Heart Disease
7%
Genetic Disorder
7%
Adverse Event
7%
Nausea
7%
Focal Epilepsy
7%
Adverse Drug Reaction
7%
Treatment Group
7%
Epileptic State
7%
Diabetic Neuropathy
6%
Malignant Neoplasm
6%
Psychotropic Agent
6%
Narcotic Agent
6%
Anticoagulant Agent
5%
Virus Infection
5%
Thromboembolism
5%
Cerebrovascular Disease
5%
Muscle Injury
5%